Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors
about
Predictive value of CHFR and MLH1 methylation in human gastric cancer.Fancf-deficient mice are prone to develop ovarian tumoursThe role of epigenetics in resistance to Cisplatin chemotherapy in lung cancerThe Fanconi anemia pathway and ubiquitinThe ubiquitin system, disease, and drug discovery.Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patientsRAD51C--a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC).Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance.Genome wide DNA methylation profiles provide clues to the origin and pathogenesis of germ cell tumors.DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminomaCisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes.Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer.Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells.Fanconi anaemia: from a monogenic disease to sporadic cancer.Epigenetics: a way to understand the origin and biology of testicular germ cell tumors.Molecular genetics of testicular germ cell tumors.Age-related biological features of germ cell tumors.Nucleic acid-based tissue biomarkers of urologic malignancies.Cisplatin resistance in germ cell tumours: models and mechanisms.Emerging Therapeutic Targets for Male Germ Cell Tumors.The epigenetics of testicular germ cell tumors: looking for novel disease biomarkers.Inhibitory effects of marine-derived DNA-binding anti-tumour tetrahydroisoquinolines on the Fanconi anaemia pathway.Current Concepts of Epigenetics in Testicular Cancer.IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer.Dimethyl sulfoxide induces chemotherapeutic resistance in the treatment of testicular embryonal carcinomas.Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.Association Between RASSF1A Promoter Methylation and Testicular Germ Cell Tumor: A Meta-analysis and a Cohort Study.Incorporating DNA Methyltransferase Inhibitors (DNMTis) in the Treatment of Genitourinary Malignancies: A Systematic Review.Cisplatin induces Sirt1 in association with histone deacetylation and increased Werner syndrome protein in the kidney.Alterations in gene promoter methylation and transcript expression induced by cisplatin in comparison to 5-Azacytidine in HeLa and SiHa cervical cancer cell lines.MT1G hypermethylation: a potential prognostic marker for hepatoblastoma.Targeting DNA Methyltranferases in Urological Tumors.Targeted therapies for patients with germ cell tumors
P2860
Q27852998-486B2D24-BEC1-44A9-95BB-62CD678D2C32Q28247935-25867A56-5BFD-4B1A-BE03-39B719ADF771Q28387891-48A7EF05-4C27-4F5C-8E2E-538F37F35EBDQ28756516-E7A89767-C58E-4FA6-8F89-53A8DF49132DQ33384295-5FDE20E5-E6F8-41C2-8437-F90EEB200D49Q33796956-3562E8B5-B772-4C5D-A08F-1B23BFD6257DQ33797039-AE3A32CD-18FF-46B0-ABA9-26EFF5D892A4Q34502557-FD2732C3-596F-4605-98DE-866FBB8704B1Q35208036-4D8E4B61-DE32-4D75-AA9D-71A5A416B0FCQ35598887-F4822BBA-4E7E-40E1-8146-F920F2F67EB7Q35682021-A18C5909-2036-4CF0-8850-D733DEE7E1C7Q36105474-C32C45E4-AE5B-4C8D-88B8-4578FB0EFC45Q36615636-F5E12F7F-FDCE-4D60-A499-A71459A39433Q37523040-3F713FBE-F378-4EEC-8599-DE6670762BD6Q37865169-A7E6C67B-318E-4CC1-8E78-2992BD8CED13Q37989167-7EFA1285-2A42-4D79-BC2C-0BD914E4DE0EQ37995190-2E9EA189-09A6-4B7B-A4C2-4962854B0449Q38169125-5B213F8B-3F40-4D93-95E7-015DC2DD837DQ38216131-7157A54C-8B7B-4B0D-A6FF-DE445B84883BQ38302534-01793A79-69DE-4489-8FB8-87518E42BF56Q38602699-FF67C9E5-5BFE-4486-BAA4-9EDABBF8376CQ39093289-53402C81-3CBB-457F-8F42-5771B05C4F1CQ39111478-F11BF504-235A-4A85-B342-23C448BF7683Q39331536-244F67CA-B0C2-49FA-B8C8-5B333E829415Q39356827-B0D2B724-55B1-45E0-A436-3B1CE5A60867Q40257827-81467222-0D12-415D-A5F5-146077353E6CQ40432298-7D90FD8F-B415-4505-A326-EF9A6EA6D3A0Q41664037-BFB2D396-93CE-4D4C-94CE-A81ECFB3649CQ48136845-D16B4922-8A21-42DF-9F03-B0D45B22738BQ53260628-6A4DBD0B-99E2-46C8-ABD5-F0DB6448287EQ53583373-B9872869-7397-4292-9420-4F8FC94F51DBQ55052484-CE0AF791-7745-4243-A156-61EEF067B543Q55435258-D4A7FC0A-1E6C-4D23-9AAC-05BA358C43EFQ57837665-6954DC6E-9892-4A8D-BBA1-26546F03F831
P2860
Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Role of promoter hypermethylat ...... ponse of male germ cell tumors
@ast
Role of promoter hypermethylat ...... ponse of male germ cell tumors
@en
Role of promoter hypermethylat ...... ponse of male germ cell tumors
@nl
type
label
Role of promoter hypermethylat ...... ponse of male germ cell tumors
@ast
Role of promoter hypermethylat ...... ponse of male germ cell tumors
@en
Role of promoter hypermethylat ...... ponse of male germ cell tumors
@nl
prefLabel
Role of promoter hypermethylat ...... ponse of male germ cell tumors
@ast
Role of promoter hypermethylat ...... ponse of male germ cell tumors
@en
Role of promoter hypermethylat ...... ponse of male germ cell tumors
@nl
P2093
P2860
P356
P1433
P1476
Role of promoter hypermethylat ...... ponse of male germ cell tumors
@en
P2093
Adel M Assaad
Deborah L Dobrzynski
Gopeshwar Narayan
James M McKiernan
Jane Houldsworth
Jennifer Bacik
Mahesh Mansukhani
Raju S K Chaganti
Sanjay Koul
Victor E Reuter
P2860
P2888
P356
10.1186/1476-4598-3-16
P407
P577
2004-05-18T00:00:00Z
P5875
P6179
1016725799